Atara Biotherapeutics Inc (NAS:ATRA)
$ 10.28 -1.35 (-11.61%) Market Cap: 58.33 Mil Enterprise Value: 83.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Q3 2023 Atara Biotherapeutics Inc Earnings Call Transcript

Nov 01, 2023 / 01:00PM GMT
Release Date Price: $31.5 (-2.33%)
Operator

Good morning, and thank you for standing by. Welcome to Atara Biotherapeutics' third-quarter 2023 financial results conference call. (Operator Instructions) Please be advised that today's call is being recorded. I would now like to hand the call over to Alex Chapman, Vice President of Corporate Communications and Investor Relations at Atara Biotherapeutics. Please go ahead, sir.

Alex Chapman
Atara Biotherapeutics, Inc. - VP, Corporate Communications & IR

Thank you, Cheri. Good morning, everyone, and welcome to Atara's conference call to discuss our expanded tab-cel global partnership with Pierre Fabre Laboratories and our third-quarter 2023 update. Earlier today, we issued a press release announcing this partnership and our third-quarter financial results. This press release and an updated slide deck are available in the investors and media section at atarabio.com.

Joining me on today's call are Dr. Pascal Touchon, President and Chief Executive Officer, and Eric Hyllengren, Chief Financial Officer. (Event Instructions)

We would like to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot